Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?

导出 OA

翻译打印收藏纠错

作者： Rachel,Huddart ^[1] ; Katrin,Sangkuhl ^[1] ; Michelle,Whirl-Carrillo ^[1] ; Teri E,Klein ^[1]

作者单位： Department of Biomedical Data Science, Stanford University, Stanford, California, USA. ^[1] Department of Medicine, Stanford University, Stanford, California, USA. ^[2]

主题词抗药性(Drug Resistance);人类(Humans);遗传药理学(Pharmacogenetics);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1002/cpt.1420

PMID 30977517

发布时间 2020-08-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览15

Clinical pharmacology and therapeutics

2019年106卷2期

284-286页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?

Clinical pharmacology and therapeutics

相似文献

Clinical pharmacology and therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?

Clinical pharmacology and therapeutics

相似文献

Clinical pharmacology and therapeutics

相关期刊

检索历史清除